|
|
Research
Our objective at Day One is to develop monitoring solutions that can provide accurate and objective measurements of neurologic improvement or decline in neonatal patients. Our current research is focused on analysis methods to:
- provide a reliable trend of general neurological assessment
- accurately identify the duration and location of seizures
Research in these areas has been funded in part by the National Institute of Child Health and Human Development (NICHD) and the National Institute of Neurological Disorders and Stroke (NINDS).
Prototype Seizure Detection Display for NEO
|
|
The NEO™ research monitor is currently being used in IRB-approved research studies to help evaluate our specialized neonatal analysis metrics. The NEO is closely related to the commercially-available CNS Monitor, which has received FDA clearance as a general-purpose EEG system that can be used for monitoring patients of all ages (from neonates to adults).
The NEO has been used within neurodiagnostic studies by the NICHD Neonatal Research Network (part of the National Institutes of Health). The purpose of these studies is to assess the effectiveness of treatments (such as hypothermia) to minimize neurological deficits in the infant brain.
Day One Medical is involved in several research projects where EEG needs to be recorded, analyzed, and stored. If you are interested in participating in one of our validation studies, or proposing some new collaborative research, please contact us at dayone-research@moberg.com.
|
|
Notice: FDA 510(k) clearance for sales of the CNS Monitor within the U.S. was received on November 5, 2008. Please contact us for pricing and availability or if you would like further information.
|
|
|
